# Centurium Capital

> Centurium Capital is a VC fund in Beijing backing Software and Biotechnology. See 32 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 32
- Last investment: Mar 2026
- Lead investor: 63%
- Last fund: Dec 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/centurium-capital/
- Website: http://www.centurium.com/en

Centurium Capital is a VC fund in Beijing focused on Software and Biotechnology. Centurium Capital, founded by former head of Warburg Pincus Asia, is a leading Greater China focused private equity firm.

## Contacts

5 contacts available for Centurium Capital. Shizune tracks 6 team members at Centurium Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/centurium-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 5 | 16% |
| Biotechnology | 5 | 16% |
| Health Care | 4 | 13% |
| Pharmaceutical | 4 | 13% |
| Logistics | 3 | 9% |

51 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 9 | 28% |
| Series D | 5 | 16% |
| Series A | 4 | 13% |
| Series B | 4 | 13% |
| Private Equity | 4 | 13% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 23 | 72% |
| Israel | 1 | 3% |
| Hong Kong | 1 | 3% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael Chen | Partner and Managing Director | 1 | https://shizune.co/investors/profile/michael-chen-10 |
| Yunze Chen | Vice President | 0 | https://shizune.co/investors/profile/yunze-chen |
| Zhixing Chen | Director | 2 | https://shizune.co/investors/profile/zhixing-chen |
| David Li | Founder, Chairman & Chief Executive Officer | 2 | https://shizune.co/investors/profile/david-li-2 |
| Mingxia Li | Chief Communications Officer | 0 | https://shizune.co/investors/profile/mingxia-li |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Excalipoint Therapetics | Excalipoint Therapeutics is a Private limited company. | $27.7M | Seed | Mar 18, 2026 |  |
| LASO Biotech | Genebox is a leading consumer genetics company. |  | Series B | Nov 26, 2025 |  |
| Innogen Pharmaceutical | Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. |  | Private Equity | Jan 01, 2024 |  |
| MitrAssist | MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality.MitrAssist has developed a new approach to treating MR that is neither repair nor replacement. Instead, its proprietary valve implant is placed on top of the natural valveto work in unison with it and to enhance valve functionality.MitrAssist’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients. It has significant advantages over minimally invasive solutions – both existing and in development. | $100M | Series C | Sep 26, 2023 |  |
| Yogo Robot | Yogo Robot is a robotics company dedicated to developing automated delivery solutions. Yogo Robot offers an open, extensive, and versatile multi-robot ecological system that consists of smart delivery stations, robotic couriers, and Internet of Things devices. The system boosts efficiency in last-mile delivery and provides a more seamless userexperience than ever before. Yogo Robot is transforming how goods are transported and reimagining how humans and robots will coexist in the future by enabling the delivery industry with cutting-edge robotic technology at the terminal end. |  | Series C | Oct 21, 2022 |  |
| NTX™ | NTX™ is committed to creating revolutionary textile solutions through continuous research and innovation that are ecologically and economically sustainable. | $200M | Series C | Jul 31, 2022 |  |
| Da Yu Deng Yu Jiu | Da Yu Deng Yu Jiu is a light-stroke bubble wine brand that manufactures and produces low-level wine drinks for the public. | $15.7M | Series A | Apr 13, 2022 |  |
| seyond | The goal of Seyond is to develop, construct, and manufacture in large quantities the most advanced LiDAR systems with the best performance in the globe. |  | Private Equity | Jan 01, 2022 |  |
| Reading Technology | Reading Technology is an R&D company that uses imaging, data, AI diagnosis, and treatment technology for heart and brain diseases. |  | Series A | Nov 26, 2021 |  |
| Meican | Meican.com (美餐) is a platform and website focused on providing mobile ordering of foods, detailed take-out menus as well as personal and enterprise meal ordering services. It enables users choose meals by themselves from many cooperative restaurants and enjoy personalized delicacy. Meican.com also enables enterprises become efficient in terms ofdelivering orders as well as solving the problems of food classification and settlement so that they can focus on their core business.Meican.com has vast experience of product research and development and offline operation due to its professional team. Established in Jan. 2011, Meican.com covers four major cities like Beijing, Shanghai, Guangzhou and Shenzhen, and it owns more than 30,000 cooperative restaurants. | $100M | Series E | Nov 11, 2021 |  |

10 of 32 investments shown.

## Co-investors
- [Joy Capital](https://shizune.co/investors/profile/joy-capital) — VC Fund, 3 deals together
- [6 Dimensions Capital](https://shizune.co/investors/profile/6-dimensions-capital) — VC Fund, 2 deals together
- [CITIC Capital Holdings](https://shizune.co/investors/profile/citic-capital-holdings) — VC Fund, 2 deals together
- [GIC](https://shizune.co/investors/profile/gic) — VC Fund, 2 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 2 deals together
- [Anhui Huawen Capital Investment Management](https://shizune.co/investors/profile/anhui-huawen-capital-investment-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Imaginary Ventures](https://shizune.co/investors/profile/imaginary-ventures) — VC Fund
- [Distill Ventures](https://shizune.co/investors/profile/distill-ventures) — VC Fund
- [InvestBev](https://shizune.co/investors/profile/investbev) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Wine And Spirits Investors in Asia](https://shizune.co/investors/wine-and-spirits-investors-asia)
- [Wine And Spirits VC Funds in Asia](https://shizune.co/investors/wine-and-spirits-vc-funds-asia)

## FAQ

### What does Centurium Capital invest in?

Centurium Capital invests primarily in Software, Biotechnology and Health Care startups, most often at Series C and Series D stage. Most of the 32 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Centurium Capital?

Public channels for Centurium Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Centurium Capital?

The team at Centurium Capital includes Michael Chen (Partner and Managing Director), Yunze Chen (Vice President) and Zhixing Chen (Director), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co